Josh Canavan

Josh Canavan is the head of pharmacy at RazorMetrics.

Articles by Josh Canavan

Scientist analyzing biosimilars for quality and efficacy, drug comparison, pharmaceutical standards | © Photo18@desing - stock.adobe.com (952831370)

From Promise to Proof: The Shakeup in Today’s Biosimilar Market

May 19th 2026

Latest Updated Articles

Trending on Pharmaceutical Commerce

Pharma Pulse: Overton's FDA Bid, EVERSANA's AI Expansion, and a Landmark Cancer Vaccine

Will PBMs' TrumpRx Price Pledge Reach Prescribers?

Report: Mail-Order Pharmacy Satisfaction Climbs as Retail Trust Slips

Michelle Britt on the Three Forces Reshaping Independent Pharmacy Economics

AI In Pharmacovigilance: The Commercial and Market-Access Imperative